Orin Hirschman 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-09 4:05 pm Sale | 2024-10-02 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Orin Hirschman | 0 0.000% | -1,061,509 (Position Closed) | Filing |
| 2024-02-07 09:15 am Purchase | 2024-01-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Orin Hirschman | 1,061,509 8.200% | 1,061,509 (New Position) | Filing |